Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Consort Medical First Half Profit Falls Due To Cramlington Incident

Tue, 03rd Dec 2019 09:14

(Alliance News) - Consort Medical PLC on Tuesday said its interim profit was considerably smaller following an incident at its Aesica Cramlington manufacturing facility.

Consort's pretax profit for the six months ended October 31 was GBP1.2 million, far less than the GBP9.6 million profit posted the year before as revenue fell 4.3% to GBP146.0 million from GBP152.5 million.

This was primarily caused by the Cramlington incident, in which a small area of the Northumberland-based operating plant was damaged in what was described by Consort at the time as "the rapid thermal degradation of a chemical resulting in the expulsion of material and contamination of the facility".

This hurt the performance of its active pharmaceutical ingredients and finished dose manufacturing unit, Aesica, where revenue fell 11% to GBP81.1 million from GBP90.9 million.

Bespak, Consort's drug delivery devices unit, was unaffected, with revenue up 5.4% at GBP64.9 million versus GBP61.6 million the year prior.

On November 18, following the end of its first half, contract development and manufacturing pharmaceutical company Consort agreed to a GBP505 million bid from Swedish peer Recipharm AB. Recipharm will pay 1,010 pence in cash for each Consort share. The proposed deal implies an enterprise value of GBP627 million for Consort.

Given that Recipharm may reduce its acquisition consideration if any dividend or other distribution is made by the Hemel Hempstead-based company, Consort has opted not to declare an interim dividend.

Consort Chief Executive Jonathan Glenn said: "The board's expectations for the full year remain unchanged. We anticipate that the group's performance in the second half of the year will benefit from continued growth in Bespak, recommencing manufacture of the specific product involved in the Cramlington incident and a reduction in the backlog at Aesica.

"The group is subject to a recommended offer from Recipharm Holdings Ltd. The board remains confident of Consort's future prospects."

Shares in Consort were down 0.5% at 1,040.00 pence in London on Tuesday morning.

By Anna Farley; annafarley@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
30 Sep 2014 08:56

Consort Medical To Acquire Aesica Holdco For GBP230.0 Million (ALLISS)

Read more
12 Sep 2014 10:17

INSIGHT-As Big Tobacco takes up e-cigarettes, investors look ahead

* Sector not as attractive for private funds as it once was * NJOY piques interest of Big Tobacco and Pharma-sources * Gamucci close to fund raising, new product launch-CEO * BAT says nicotine inhaler licensed as medical product By Martinne Geller and Jilian Mincer L

Read more
12 Sep 2014 08:34

UPDATE 1-BAT nicotine inhaler licensed as medicinal product in UK

* Cigarette-shaped Voke Inhaler wins licence from MHRA * Further licensing needed before commercialisation * No heat or vapour, in contrast to e-cigarettes * BAT unit working with Kind Consumer, Consort Medical (Adds interview with Nicoventures executive, further details) <

Read more
12 Sep 2014 06:59

Consort Medical Says Voke Inhaler Gets Marketing Authorisation

Read more
12 Sep 2014 06:23

BAT nicotine inhaler licensed as medicinal product in UK

LONDON, Sept 12 (Reuters) - A new nicotine inhaler to be sold by a unit of British American Tobacco has been licensed in the UK as a medicinal product, marking the arrival of a new competitor in the fast-growing electronic cigarette market. The Voke Inhaler contains no electronics, heat or

Read more
4 Sep 2014 10:17

Consort Medical confident for full-year after in-line trading

Consort Medical has continued to trade in line with its expectations and the board is confident of its outlook for the full year. The medical devices maker described its financial position as remaining strong, with cash at the end of August totalled £33.6m. "The board expects its sustained organi

Read more
4 Sep 2014 08:09

Consort Medical Trading Says UK Patent Box Regime To Cut Tax Rate

Read more
4 Sep 2014 07:39

REPEAT: UK MORNING BRIEFING: Standard Life Jumps 10% On Canada Sale

Read more
4 Sep 2014 07:37

UK MORNING BRIEFING:

Read more
4 Sep 2014 05:22

UK AGM, EGM Calendar - Week Ahead

Read more
3 Sep 2014 15:12

UK AGM, EGM Calendar - Week Ahead

Read more
3 Sep 2014 05:19

UK AGM, EGM Calendar - Week Ahead

Read more
2 Sep 2014 15:05

UK AGM, EGM Calendar - Week Ahead

Read more
2 Sep 2014 05:24

UK AGM, EGM Calendar - Week Ahead

Read more
1 Sep 2014 15:12

UK AGM, EGM Calendar - Week Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.